Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Anatomic Considerations in Thyroid Eye Disease
source: Ophthalmic Plastic and Reconstructive Surgery
year: 2018
authors: Dutton JJ
summary/abstract:Purpose:
To review and summarize the clinical findings in thyroid eye disease (TED) related to the unique anatomical structures of the eyelids and orbit.
Methods:
A PubMed search was performed searching for anatomical relationships between eyelid and orbital anatomy and the clinical findings of TED.
Results:
The major clinical findings associated with TED are varied. They typically involve both the eyelid and the orbit. In the eyelid, usual findings include upper eyelid retraction, contour abnormalities, eyelid edema, prolapsed orbital fat, conjunctival injection and chemosis, caruncular edema, and meibomian gland dysfunction. The exact causes of these changes remain a matter of controversy, but numerous hypotheses have been proposed, most with limited experimental support. In the orbit, inflammation and congestion characterize the acute active phase, with tissue expansion and fibrosis persisting into the chronic inactive phase. All of these findings result, at least in part, from the unique anatomy of the eyelids and orbit and their interaction with the immunologic processes underlying TED. Here we review these major characteristics of TED, with special reference to their anatomic relationships.
Conclusions:
The major findings characterizing TED are related to unique anatomic features in the eyelid, including Müller muscle, the levator palpebrae superioris muscle, and suspensory ligaments of the conjunctiva. In the orbit, Graves-related remolding results from the special physiologic features of the extraocular muscles, the structure of the orbital walls and their relations to adjacent paranasal sinuses, and the reaction of orbital fat to immunologic challenges.
DOI: 10.1097/IOP.0000000000001122
read more
myBinderRelated Content
-
Total Thyroidectomy (Tx) Versus Thionamides (Antithyroid Drugs) in Patients With Moderate-to-Severe Graves’ Op...Background: Graves' disease (GD) is cha...
-
Jimmy Uddin, MB Bchir, MA, FRCOphthJimmy Uddin is a Senior Consultant Ophth...
-
Clinical Characteristics of Patients Requiring a Second Dose of Radioactive Iodine for the Treatment of Graves’ Di...Graves’ disease is an autoimmune condi...
-
Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves’ OrbitopathyImportance: Graves orbitopathy (GO) res...
-
A Prospective, Randomized Trial of Intravenous Glucocorticoids Therapy With Different Protocols for Patients With Gr...Background: For patients with active mo...
-
Teprotumumab and the Evolving Therapeutic Landscape in Thyroid Eye DiseaseContext: Thyroid eye disease (TED) is a...
-
“TED Today” Episode 1https://www.facebook.com/ThyroidEyes/vid...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Google